Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial-Reference-Cited by-同舟云学术

Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial

Published:2011-08-11 Issue:3 Volume:271 Page:257-263
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:

Author:

Burkard T.,Kaiser C. A.,Brunner-La Rocca H.,Osswald S.,Pfisterer M. E.,Jeger R. V.,

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2796.2011.02423.x/fullpdf

Reference27 articles.

1. Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

2. Effect of a prior authorization process on antiplatelet therapy and outcomes in patients prescribed clopidogrel following coronary stenting;Ackman;Can J Cardiol,2006

3. Restrictive access to clopidogrel and mortality following coronary stent implantation;Sheehy;CMAJ,2008

4. The BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. An observational study of drug-eluting versus bare-metal stents;Pfisterer;J Am Coll Cardiol,2006

5. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee;King;Circulation,2008

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse cardiovascular outcomes associated with proton pump inhibitor use after percutaneous coronary intervention: a systematic review and meta-analysis;BMC Cardiovascular Disorders;2024-07-17

2. Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis;Frontiers in Pharmacology;2023-01-10

3. Association of Proton Pump Inhibitor and Infection and Major Adverse Clinical Events in Patients With ST-Elevation Myocardial Infarction: A Propensity Score Matching Analysis;Frontiers in Medicine;2022-05-04

4. Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis;International Journal of Clinical Pharmacy;2021-03-28

5. The potential interaction of statins and clopidogrel in patients undergoing percutaneous coronary intervention;International Journal of ADVANCED AND APPLIED SCIENCES;2021-03